Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,230.12
(
0.29%
)
US TECH 100
26,942.00
(
0.87%
)
Dow Jones
49,499.27
(
-0.31%
)
Brent Oil
107.80
(
0.00%
)
Bitcoin
78,756.52
(
0.10%
)
News Focus
News Focus
Post# of 648882
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Tuff-Stuff

Send PM Follow Ignore
Followers 217
Posts 247348
Boards Moderated 2
Alias Born 04/06/2006

Tuff-Stuff

Re: Tuff-Stuff post# 531309

Wednesday, 01/22/2014 7:02:17 AM

Wednesday, January 22, 2014 7:02:17 AM

Post# of 648882
AZN $65.00>European regulators have approved AstraZeneca's (AZN) Xigduo treatment for Type 2 diabetes.
The authorization is the first for a drug that combines an SGLT2 inhibitor, which cuts the reabsorption of excess glucose, and metformin, a standard therapy

Pray for A Pain Free Day!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today